Hamilton Thorne Ltd. (CVE:HTL – Get Free Report) rose 4.3% during trading on Monday . The company traded as high as C$1.45 and last traded at C$1.45. Approximately 25,700 shares traded hands during trading, a decline of 27% from the average session volume of 35,118 shares. The stock had previously closed at C$1.39.
Hamilton Thorne Stock Up 4.3%
The firm’s 50 day moving average price is C$1.45 and its two-hundred day moving average price is C$1.45. The firm has a market capitalization of C$149.69 million, a PE ratio of 58.94 and a beta of 0.54. The company has a quick ratio of 2.25, a current ratio of 2.04 and a debt-to-equity ratio of 43.24.
Hamilton Thorne Company Profile
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.
Featured Articles
- Five stocks we like better than Hamilton Thorne
- Quantum Computing Is Raising the Stakes for Cybersecurity: 5 Stocks to Watch
- 5 Stocks to Buy in September Before Wall Street Catches On
- PDD Beat Earnings—So Why Did the Stock Still Fall?
- Tariffs Are Back in Focus: 3 Stocks With a Home-Field Advantage
Receive News & Ratings for Hamilton Thorne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Thorne and related companies with MarketBeat.com's FREE daily email newsletter.
